B.GRIMM Pharma enhances access to quality medicines, improving people’s quality of life and supporting public health in Thailand. Mr. Panya Kitcharoenkankul, Head of B.GRIMM Pharma, represented the company in donating medicines for the treatment of Pulmonary Arterial Hypertension (PAH) valued at THB 1 million to Siriraj Hospital.

This initiative supports patients in accessing treatment and living fuller lives, while continuing to deliver high-quality healthcare products under the vision of “Compassionately Pioneering Health for All Lives.”

1. B.GRIMM Pharma’s SMART Commercial Leadership program

This initiative supports patients in accessing treatment and living fuller lives, while continuing to deliver high-quality healthcare products under the vision of “Compassionately Pioneering Health for All Lives.”

2. Key Contributions

• Supporting equitable access to essential PAH treatment
• Enhancing quality of life for patients through continued care
• Strengthening collaboration with leading healthcare institutions
• Reinforcing B.GRIMM Pharma’s commitment to sustainable public health impact

Looking Ahead

B.GRIMM Pharma remains dedicated to advancing healthcare accessibility and supporting initiatives that create meaningful impact for communities across Thailand. Guided by compassion and innovation, the company will continue delivering high-quality healthcare solutions that contribute to healthier and more sustainable lives for all.